TRT and HCG on TikTok: separating real risks from gym-bro mythology

What did @personal_trainer.rodolfo actually say?

Honestly, this is a tough one to fact-check cleanly. The transcript is essentially inaudible, captured as garbled phonetic noise rather than coherent speech. The caption, written in Spanish, does the heavier lifting here. Rodolfo warns that uncontrolled use of TRT and HCG can cause "irreparable damage" or even death. He also draws a line between therapeutic hormone use and using these compounds for muscle development in athletic disciplines, which is a real and important distinction that most fitness influencers blur completely. We're working from the caption, not a clear transcript, so take the specifics with that caveat in mind.

The caption frames HCG as something used alongside TRT, describes risks of unsupervised use, and nods toward the difference between medical replacement therapy and performance enhancement. That framework is not wrong, even if the delivery is incomplete.

Does the science back this up?

On the core warning, yes. Unmonitored testosterone and HCG use carries real, documented risks, and the literature is not subtle about it. The claim that unsupervised use can cause serious harm is accurate and supported by multiple lines of evidence.

Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis, reducing LH and FSH secretion, which leads to testicular atrophy and impaired spermatogenesis. This is not controversial. Ramasamy et al. (2014, Fertility and Sterility) documented significant declines in sperm production among men on exogenous testosterone, with some experiencing prolonged or irreversible azoospermia. HCG, which mimics LH, is used in clinical TRT protocols precisely to preserve testicular function and fertility during treatment.

On the cardiovascular side, Baggish et al. (2017, Circulation) found structural cardiac changes, including increased left ventricular mass and impaired diastolic function, in long-term anabolic steroid users compared to non-users. The mortality implication in the caption is supported by epidemiological data, though pinning a single cause-of-death to unsupervised TRT specifically is harder to isolate from broader AAS misuse patterns.

What did they get wrong (or right)?

Rodolfo gets credit for drawing a distinction between therapeutic TRT and performance-enhancing use. That line matters clinically and legally, and most fitness creators ignore it entirely or actively obscure it. The warning that unsupervised use can cause irreparable harm is accurate and appropriate.

What he doesn't do, at least in the caption, is specify what responsible monitoring actually looks like. Saying something is dangerous without explaining what makes it safer leaves the audience with fear and no direction. For a viewer already self-administering testosterone they bought online, "this can kill you" without any clinical roadmap is incomplete harm reduction.

There's also a vagueness problem. The phrase "irreparable damage" covers a wide range of outcomes, from fertility loss, which is sometimes reversible, to cardiac fibrosis, which is not. Lumping those together without distinguishing severity or reversibility is a form of imprecision that can erode trust or, worse, desensitize viewers who think the risk is being exaggerated.

The inaudible audio is a separate problem. If the video's core information is in the spoken content and viewers can't hear it clearly, the educational value collapses.

What should you actually know?

HCG has a specific, documented role in TRT protocols for men who want to preserve fertility or testicular volume. It works by stimulating Leydig cells directly, bypassing the suppressed LH signal. Liu et al. (2009, Journal of Clinical Endocrinology and Metabolism) showed that HCG co-administration during testosterone therapy maintained intratesticular testosterone levels, which are critical for spermatogenesis, at near-normal concentrations.

This is not the same as saying HCG is a performance-enhancing drug. In the context of medically supervised TRT, it is a tool for preserving a specific physiological function. Outside that context, its use is not supported by evidence for muscle gain or athletic performance in men with normal gonadal function.

• TRT requires baseline bloodwork before initiation: total testosterone, free testosterone, LH, FSH, hematocrit, PSA, and a lipid panel at minimum.
• Polycythemia is a real and underreported risk. Hematocrit elevation above 54% increases thrombotic risk significantly (Glueck et al., 2014, Clinical and Applied Thrombosis/Hemostasis).
• Cardiovascular monitoring is not optional. The Baggish data on cardiac remodeling applies even to therapeutic doses in some populations.
• Fertility considerations should be addressed before starting TRT, not after. Recovery of spermatogenesis after testosterone cessation is not guaranteed and can take 12-24 months or longer.

If you are considering TRT, work with a physician who orders labs and follows up on them. A trainer on TikTok, even one making accurate points about risk, is not a substitute for that.